Low doses of bovine somatotropin during the transition period and early lactation improves milk yield, efficiency of production, and other physiological responses of Holstein cows

The objectives of this experiment were to determine whether low doses of bovine somatotropin (bST) during the transition period and early lactation period improved dry matter intake (DMI), body weight (BW), or body condition score (BCS); provoked positive changes in concentrations of somatotropin, insulin, insulin-like growth factor-I (IGF-I), glucose, nonesterified fatty acids, and Ca; or improved milk yield (MY) response without obvious adverse effects on health status. Eighty-four multiparous Holstein cows completed treatments arranged in a 2 x 3 x 2 factorial design that included prepartum and postpartum bST, dry period (30 d dry, 30 d dry + estradiol cypionate, and 60 d dry), and prepartum anionic or cationic diets. Biweekly injections of bST began at 21 +/- 3 d before expected calving date through 42 +/- 2 d postpartum (control = 0 vs. bST = 10.2 mg of bST/d; POSILAC). At 56 +/- 2 d in milk, all cows were injected with a full dose of bST (500 mg of bST/14 d; POSILAC). During the prepartum period and during the first 28 d postpartum, no differences in mean BW, BCS, or DMI were detected between the bST treatment group and the control group. During the first 10 wk of lactation, cows in the bST treatment group had greater mean MY and 3.5% fat-corrected milk yield and lower SCC than did cows in the control group. When cows received a full dose of bST, an increase in milk production through wk 21 was maintained better by cows in the bST group. Mean concentrations of somatotropin, IGF-I, and insulin differed during the overall prepartum period (d -21 to -1). During the postpartum period (d 1 to 28), cows in the bST group had greater mean concentrations of somatotropin and IGF-I in plasma. Concentrations of Ca around calving did not differ because of bST treatment. Results suggest that changes in concentrations of blood measures provoked by injections of bST during the transition period and early lactation period resulted in improved metabolic status and production of the cows without apparent positive or negative effects on calving or health.     

Effects of bovine somatotropin on milk yield and composition in Holstein cows in advanced lactation fed low- or high-energy diets

The objective of this study was to evaluate the response of Holstein cows to bovine somatotropin (bST) during advanced lactation and its relationship to energy intake. Twenty-four lactating Holstein cows averaging 21 kg of milk/d, and 292 d in milk were assigned to one of three treatment groups in a randomized block design. Blocks were based on the 14 d of pretreatment milk production, and treatment groups were balanced for days in milk. Treatment 1 was a low-energy diet (1.49 Mcal/kg of dry matter) without bST injection; treatment 2 was the low-energy diet plus injection of 500 mg of bST every 14 d; and treatment 3 was a high-energy diet (1.71 Mcal/kg of dry matter) with bST injections as in treatment 2. Treatment was divided into two periods (1 to 49 and 50 to 98 d) to determine if response to bST and energy changed with time on treatment. Results showed that bST significantly (P < 0.05) increased milk, fat-corrected milk, and fat and protein yields; and feed efficiency (fat-corrected milk per dry matter intake) for both periods. Milk yield responses to bST were greater for cows fed the low-than the high-energy diet in both periods. These data show that bST injections for cows in advanced lactation increased performance, but excessive energy diminished the bST response.     

Evaluation of sometribove in a prolonged-release system in lactating dairy cows--production responses

Primiparous (n = 105) and multiparous (n = 136) Holstein cows were used to evaluate efficacy of sometribove (n-methionyl bovine somatotropin, bST) in a dose titration study. Cows were fed TMR for ad libitum intake, were milked twice daily, and were allocated randomly within parity (1 vs. 2+) to treatments of 0, 250, 500, or 750 mg bST/14 d in a prolonged-release formulation. Subcutaneous injections commenced 60 +/- 3 d postpartum and continued throughout lactation. During a standardized treatment period of 252 d, treatment with increasing dosages of bST increased 3.5% FCM yield in a dose-dependent manner for both primiparous (2.5 kg/d, 10.2%; 3.5 kg/d, 14.3%; and 5.9 kg/d, 24.1%) and multiparous cows (3.1 kg/d, 12.1%; 3.9 kg/d, 15.2%; and 6.8 kg/d, 26.5%). Milk content of fat, protein, lactose, ash, Ca and P, and SCC were not affected by treatment. Over the 252-d treatment period, voluntary intake of energy was increased in bST-treated cows such that BW gain, body condition score, and net energy balance did not differ among treatment groups. Productive efficiency (milk per unit NEL intake corrected for BW change) over the treatment period was significantly increased in a dose-dependent manner for multiparous cows (4.1, 6.8, and 11.0%). Results demonstrated that bST administered in a prolonged-release formulation was efficacious in enhancing milk production and feed efficiency.     

Metabolic and production responses to dietary protein and exogenous somatotropin in late gestation dairy cows.

Forty-three multiparous Holstein cows were used in a completely randomized design to evaluate the effects of protein supplementation and the use of bovine somatotropin (bST; Posilac, Monsanto Co., St. Louis, MO) in late gestation on animal metabolism and productivity in the periparturient period. Treatments were initiated 28 d prior to expected calving date and continued through parturition. Diets contained either 13.3 or 17.8% crude protein and were formulated to be similar in profile of protein fractions. Within each dietary treatment, cows were assigned to receive either 0 or 500 mg of sustained released bST once every 14 d until parturition. Following parturition, all cows were subjected to the same management and dietary treatments, and production measurements were followed until 42 d in milk. The use of bST increased plasma glucose and decreased plasma nonesterified fatty acids and beta-hydroxybutyrate prior to calving. Despite these changes in metabolism, bST did not affect concentrations of fat and triglyceride in the liver prepartum or postpartum. Feeding the 17.8% protein diet failed to stimulate glucose metabolism and tended to elevate plasma beta-hydroxybutyrate in late gestation. Cows treated with bST produced 3.3 kg/d more milk than did controls across the first 42 d of lactation; the difference was 4.6 kg/d in wk 6 of lactation. The use of bST in late gestation has considerable promise to alter cow metabolism positively. The results of these and other possible periparturient responses to somatotropin may increase milk production in early lactation.     

Administration of bovine somatotropin in early lactation: a meta-analysis of production responses by multiparous Holstein cows

A meta-analysis was conducted to assess production responses before 90 d in milk (DIM) when bovine somatotropin (bST) administration was initiated between 5 and 35 DIM. The database was developed from 13 studies of multiparous cows that were published between 1985 and 2006 and from an unpublished study that complied with the study selection criteria. The database included results from 842 cows and provided 50 treatment means for the effect of bST on 3.5% fat-corrected milk (FCM) in early lactation. Effects of bST were investigated using mixed model procedures that included fixed (intercept and slope) and random (intercept and slope) effects for independent variables. Yields of milk (38.6 ± 1.3 kg/d) and FCM (37.6 ± 1.6 kg/d) by control cows before 90 DIM were increased by 2.6 ± 0.8 and 3.2 ± 0.6 kg/d by bST administration. Fat content in milk from bST-treated cows was 0.31 ± 0.10 percentage units greater than that from control cows (3.46 ± 0.13%) but milk protein content (2.95 ± 0.03%) was not altered by bST. Milk fat (1.39 ± 0.10 kg/d) and protein (1.15 ± 0.04 kg/d) yields by controls were increased 0.16 ± 0.03 and 0.07 ± 0.03 kg/d by bST, respectively. Dry matter intake and body weight loss were not altered by bST before 90 DIM, but duration of negative energy balance was prolonged and overall energy balance during this interval reduced when cows were treated with bST. Results are consistent with the premise that bST-treated cows partition nutrients and energy toward milk synthesis for a longer duration and thus likely need a longer interval to replenish their body reserves than cows not treated with bST. Production responses to bST were not altered when cows consumed typical early-lactation diets supplemented with fat except that supplemental fat tended to decrease the magnitude of the effect of bST on milk fat content and decreased the effect of bST on fat and protein yield. Yield of FCM increased curvilinearly with the amount of bST administered. Results indicate that initiation of bST administration to cows before 35 DIM increased FCM yield but the response was at the low end of that typically observed when bST administration is initiated in wk 9 of lactation.     

Effects of sustained release bovine somatotropin (sometribove) on animal health in commercial dairy herds

The health of dairy cows given bovine somatotropin (bST) for one lactation was evaluated in 28 commercial herds located in four regions of the United States. At least six herds were in a region and at least one herd/region contained fewer than 60 cows. Cows (n = 1213) were assigned randomly to control or bST groups and were treated beginning in wk 9 to 10 of lactation and every 14 d until dry-off or d 400 of lactation. Management was according to site practices. Cows were observed for health-related signs by farm personnel daily and by the herd veterinarian biweekly. Average 305-d test-day milk yields were 932 kg greater for bST-treated cows. Pregnancy rates, days open, twinning, cystic ovaries, or abortions were unaffected by treatments. Supplementation of cows with bST had no effect on total mastitis cases, total days of mastitis, duration of mastitis, or the odds ratio of a cow to develop mastitis. Cows supplemented with bST used more medications for health events other than mastitis. This usage was associated primarily with treatments for disorders of the foot and hock. Supplemented cows had a slight increase in foot disorders. There was no effect of supplementation with bST on culling from the herd or removal from study. Overall, the results confirm that label directions for bST are adequate for safe use under field conditions. All clinical signs observed in this study occur normally in dairy herds and were managed in cows supplemented with bST.     

Effect of a prolonged-release formulation of N-methionyl bovine somatotropin (sometribove) on milk fat.

Nine Holstein cows were injected bi-weekly with a prolonged-release formulation of N-methionyl bST, and 9 cows were injected with excipient. Intramuscular injections began at 60 +/- 3 d postpartum and continued at 14-d intervals for the full lactation. Administration of bST increased production of milk, total fat, and all milk fat components measured. Average fatty acid composition of milk fat was not influenced by bST treatment. Stage of lactation had a large influence on production and percentage of individual fatty acids in milk fat from both bST-treated and control cows. The stage of lactation impact on the fatty acid composition of milk fat reflected changes in the relative contributions of body fat mobilization and de novo synthesis of milk fat components in response to changes in energy balance. Initiation of bST treatment caused some transient changes in milk fatty acid composition that were related to energy balance. These changes were small compared with the normal changes because of stage of lactation in all cows. Phospholipid and cholesterol content of milk also changed with stage of lactation but were not influenced by bST treatment. Melting properties of milk fat were influenced greatly by stage of lactation. Bovine somatotropin did not cause any changes in composition or physical properties of milk fat that were outside the range of normal variation.     

Slow release somatotropin in dairy heifers and cows fed two levels of energy concentrate. 1. Performance and body condition.

Fifty-two Holstein dairy cows (27 primiparous) were used in a 2 x 2 factorial design during wk 9 to 39 of lactation to assess the effects of slow release recombinant bST (500 mg injected at 14-d intervals) and the effects of the level of energy concentrate in the diet on dairy performance. After a winter period, cows were turned out to pasture at wk 24 of lactation. During winter, cows given low concentrate (2.5 vs. 5.4 kg DM/d) ate significantly more corn silage (13.9 vs. 11.9 kg DM/d), so that treatment had no significant effect on any measured parameter. The milk yield of bST-supplemented cows increased by 2.1 kg/d (11.0%) throughout the total experimental period. The response did not differ according to parity. Milk fat content and SCC were not altered, but milk protein was lower (.8 g/kg) from cows receiving bST during winter, and lactose increased (.5 g/kg). Lactation curves of bST-supplemented cows showed a cyclic response in milk production. Gross efficiency of milk yield was improved (.18 units) by bST administration without change in diet digestibility. No difference due to bST was found in the health or reproduction of cows. Live weight change did not differ among the groups. Multiparous cows gained body condition (bST-supplemented animals gained less than controls: .1 vs. .7 point on a five-point scale; NS). Control primiparous cows gained body condition (.1 point) but bST-supplemented cows significantly lost body condition (1.4 point).     

Responses by lactating cows in commercial dairy herds to recombinant bovine somatotropin

Cows (890) in 15 US herds were assigned randomly in equal numbers to control or bST injections (500 mg in a prolonged-release form every 14 d for 12 wk) within three stages of lactation (57 to 100, 101 to 140, and 141 to 189 d postpartum) and two parity groups (primiparous and multiparous). Yield and milk composition were monitored 1 d/wk for 16 wk including 2 wk pretreatment and 2 wk posttreatment. Increases in milk and FCM due to bST injections were less at 57 to 100 d than at 101 to 189 d postpartum (milk 3.6 vs. 5.5; FCM 3.9 vs. 6.1 kg/d per cow), and increases in milk and FCM were more for multiparous than for primiparous cows (milk 5.5 vs. 4.2; FCM 6.0 vs. 4.7 kg/d cow). Temporarily, concentration of milk fat increased and protein decreased; later, concentrations for control and injected cows were similar. Postinjection milk fat concentration decreased, but milk protein concentration increased temporarily. The net increase in milk (and FCM) varied significantly among herds from 2.9 to 7.6 kg/d per cow (mean, 4.9 kg). Responses in FCM were similar over a wide range of pretreatment yields. A great variety of feed ingredients were fed as total mixed rations, and nutrient concentrations varied greatly. The SCC were similar before, during, and after treatment, but increase in FCM of injected cows exhibited a negative correlation with pretreatment SCC. Changes in body condition score of sometribove-injected cows varied among herds (.25 to -.45) and averaged -.02 compared with .07 for controls. There was no pattern in incidence of mastitis during sometribove injections.     

Response to recombinant bovine somatotropin in dairy cows with different genetic merit for milk production

Thirty-nine multiparous cows obtained from two genetic lines were utilized to determine the effect of genetic merit on lactation response to long-term administration of recombinant bST. Cow index ranged from -70 to 456 (mean = 183) and -494 to -88 (mean = -288) kg milk for high and low genetic groups, respectively. Cows were blocked by calving date and randomly assigned to treatment within genetic group. Treatments were 0, 10.3, 20.6, and 30.9 mg somatotropin injected daily from wk 14 through 44 postpartum. Cows were fed one of two total mixed rations. Diet 1 (NE1 = 1.65 Mcal/kg, CP = 18%, and ADF = 22%) was fed from start of lactation to at least 4 wk after initiation of treatment. Cows were switched to diet 2 (NE1 = 1.56 Mcal/kg, CP = 16%, and ADF = 27%) when milk output fell below 25 kg/d. Forty-four week lactation yields were 9800 and 9447 kg milk; 364 and 354 kg fat; and 322 and 309 kg protein for high and low genetic groups, respectively. Milk, milk fat, or protein yield due to somatotropin did not differ between genetic groups. Increasing dosage of bST increased milk, 4% FCM, fat, and protein yields in a linear fashion. Percentages of fat and protein of milk were similar for all treatment groups. Body weight changes were not significantly different among treatments, but condition score changes decreased linearly with increasing dose of bST. Long-term treatment with recombinant bST had no apparent effect on incidence of health problems or reproduction.     

Effect of modified dry period lengths and bovine somatotropin on yield and composition of milk from dairy cows

Dry periods of 40 to 60 d have been an industry standard because dry periods <40 d have resulted in reduced milk yields in the subsequent lactation by 10 to 30%. However, recent research has demonstrated no production losses for cows given a 30-d dry period. The current study evaluated milk production effects of shortened or omitted dry periods for cows at mature-equivalent production >12,000 kg of milk and treated with bovine somatotropin (bST). The study used 2 commercial dairies and one university dairy and included 4 treatments. Five multiparous and 5 primiparous cows from each farm were assigned to each treatment: 1) 60-d dry period, label use of bST (60DD); 2) 30-d dry period, label use of bST (30DD); 3) continuous milking, label use of bST (CMLST); and 4) continuous milking with continuous use of bST (CMCST). Per label, bST use started at 57 to 70 d in milk and ended 14 d before drying (60DD and 30DD) or expected calving date (CMLST). In primiparous cows, average milk yields during the first 17 wk of lactation were reduced for cows on treatments 30DD, CMLST, and CMCST vs. the 60DD treatment. (38.3, 35.1, and 37.5 vs. 44.1 +/- 1.3 kg/d, respectively). For multiparous cows, respective milk yields did not differ (46.6, 43.4, 46.5, and 47.7 +/- 2.1 kg/d). Shortened or omitted dry periods may impede mammary growth in primiparous cows, resulting in reduced milk yield in the subsequent lactation. In contrast, a shortened or omitted dry period with either bST protocol did not alter production in multiparous cows treated with bST. Quality aspects of prepartum milk and colostrum require additional characterization. For multiparous cows, milk income generated for short dry periods or for continuous milking might increase their profitability. At 17 wk of the subsequent lactation, estimates of the cumulative net margins of multiparous cows on the 30DD treatment and continuous milking treatments exceeded those of cows on the 60DD treatment by 40 dollars to 60 dollars per cow.     

Anti-idiotypic responses of lactating cows immunized with monoclonal antibodies against bovine somatotropin.

The objective of this study was to produce anti-idiotypic antibodies with bovine somatotropin (bST)-like activity by active immunization of lactating cows and to determine their effects on milk yield. Several monoclonal antibodies against bST were evaluated for their interaction with bST in a rat growth bioassay. Two bST-agonist monoclonal antibodies (1 and 2), and two bST-antagonist monoclonal antibodies (3 and 4) were selected. Cows were immunized with immunoglobulin G as a control (n = 12) or with one of the four anti-bST monoclonal antibodies (1, 2, 3, 4; n = 12) on d 3, 24, 45, 66, 87, 108, 129, and 150 of lactation. From wk 3 of lactation, all cows immunized with each of the four anti-bST monoclonal antibodies developed anti-idiotypes until wk 30 of lactation. Total lactation yields were not different among monoclonal antibodies 2, 3, and 4 and control cows (9299, 9321, 9733, and 9415 kg, respectively). However, cows immunized with anti-bST monoclonal antibody 1 had reduced lactation yield compared with cows on other treatments (8136 kg). Daily milk yield of cows immunized with monoclonal antibody 1 was decreased from wk 9 of lactation [36.2 vs. 40.9 kg/d (control)] until the end of lactation, concomitantly with decreased bST concentration from wk 9 of lactation. Cows immunized with anti-bST monoclonal antibody 4 had increased milk yield compared with that of controls during wk 3 to 6 and wk 18 to 21 of lactation. Therefore, anti-idiotypes directed against anti-bST 1 had bST-antagonistic effects on lactation performance; anti-idiotypes against anti-bST 4 transiently increased milk yield.     

Bias in genetic evaluations by records of cows treated with bovine somatotropin

Records from Dairy Records Management Systems in Raleigh were used to estimate effects of bovine somatotropin (bST) treatment and to predict breeding values for milk production traits. The data comprised 5245 test-day records of bST-treated cows and 126,223 test-day records of untreated cows in first lactation for milk, fat, and protein yields. Fixed effects of bST treatment were estimated from test-day animal models with herd-test-date as another fixed factor. Percentage increases due to bST treatment ranged from 7 to 8% for test-day milk, fat, and protein yields. Random regression coefficients for additive genetic and permanent environmental effects were included in the model. To assess the potential for bias in genetic evaluations when some and not all cows are treated with bST, breeding values predicted by the test-day model with and without effects of bST treatment were compared for cows and sires. Correlations between breeding values predicted from models with and without effects of bST treatment were 0.99. However, relatively large bias was found for individual animals. This result suggests that bias in genetic evaluation caused by ignoring bST treatment may be significant.     

Association between somatic cell count during the first lactation and the cumulative milk yield of cows in Irish dairy herds

Reduced potential milk yield is an important component of mastitis costs in dairy cows. The first aim of this study was to assess associations between somatic cell count (SCC) during the first lactation, and cumulative milk yield over the first lactation and subsequent lifetime of cows in Irish dairy herds. The second aim was to assess the association between SCC at 5 to 30 d in milk during parity 1 (SCC1), and SCC over the entire first lactation for cows in Irish dairy herds. The data set studied included records from 51,483 cows in 5,900 herds. Somatic cell count throughout the first lactation was summarized using the geometric mean and variance of SCC. Data were analyzed using linear models that included random effects to account for the lack of independence between observations, and herd-level variation in coefficients. Models were developed in a Bayesian framework and parameters were estimated from 10,000 Markov chain Monte Carlo simulations. The final models were a good fit to the data. A 1-unit increase in mean natural logarithm SCC over the first lactation was associated with a median decrease in first lactation and lifetime milk yield of 135 and 1,663 kg, respectively. A 1-unit increase in the variance of natural logarithm SCC over the first lactation was associated with a median decrease in lifetime milk yield of 719 kg. To demonstrate the context of lifetime milk yield results, microsimulation was used to model the trajectory of individual cows and evaluate the expected outcomes for particular changes in herd-level geometric mean SCC over the first lactation. A 75% certainty of savings of at least €199/heifer in the herd was detected if herd-level geometric mean SCC over the first lactation was reduced from ≥120,000 to ≤72,000 cells/mL. The association between SCC1 and SCC over the remainder of the first lactation was highly herd dependent, indicating that control measures for heifer mastitis should be preferentially targeted on an individual-herd basis toward either the pre- and peripartum period, or the lactating period, to optimize the lifetime milk yield of dairy cows.     

Responses of Holstein cows to a low dose of somatotropin (bST) prepartum and postpartum

Objectives were to evaluate the effects of a low dose of bovine somatotropin (bST) injected prepartum and postpartum on body condition score (BCS), body weight (BW), and milk yield (MY) in cows as well as somatotropin insulin, insulin-like growth factor-I (IGF-I), glucose, and nonesterified fatty acids (NEFA) in plasma. Holstein cows nearing second or later parities were assigned randomly to control (CON = 98) or bST-treated (TRT = 95) groups. Biweekly injections of bST began 21 +/- 3 d before expected calving and continued through 42 d postpartum (CON vs. TRT; 0 vs. 10.2 mg of bST/ d). From 42 to 100 d postpartum, no cows received bST. During yr 1, somatotropin, IGF-I, insulin, NEFA, and glucose were measured in plasma samples from 82 cows. During yr 2, effects of bST on BCS and BW of 111 cows were evaluated, but no blood samples were collected. Milk yields through 100 d of all 193 cows were analyzed. Prepartum treatment with bST resulted in greater prepartum plasma concentrations of somatotropin, insulin, and numerically greater NEFA but did not affect glucose or IGF-I. Postpartum bST increased mean plasma concentrations of somatotropin and NEFA, but not INS, IGF-I, or glucose. Mean BCS of cows did not differ prepartum, around parturition, or postpartum. Although mean BW did not differ prepartum or around calving, cows receiving bST maintained greater BW postpartum. Cows receiving bST tended to have higher MY (6.6%) in the first 60 d of lactation, but differences did not persist through 100 d, including approximately 40 d when no cows received bST. Number of cows that were culled due to health (CON = 3 vs. TRT = 2) or died (CON = 3 vs. TRT = 1) were not affected by treatment. Low doses of bST in the transition period resulted in higher postpartum BW, quicker recovery of body condition during lactation, and significantly more milk during treatment.     

Induced lactation in nonpregnant cows: profitability and response to bovine somatotropin

Significant culling of high-producing cows with low fertility reduces profitability of dairy farms as those cows are replaced with heifers. Induced lactation of nonpregnant cows may be a management alternative to reduce culling and increase profits. The objectives of this study were to evaluate the efficacy of bovine somatotropin (bST) to increase milk production in cows induced into lactation with estrogen plus progesterone, and to determine the profitability of inducing cows into lactation vs. using replacement heifers entering the herd as first-lactation cows. Parity 1 or greater, nonpregnant, healthy Holstein cows (n = 28) were induced into lactation by administration of estradiol-17beta (0.075 mg/kg of body weight [BW] per d) and progesterone (0.25 mg/kg of BW per d) for 7 d. Milking began on d 18. Cows were randomly assigned to control or bST treatment groups on d 37 +/- 20 of milking, and milk production was compared for 70 d. After the 70-d comparison, all cows received bST for the duration of lactation. Cows receiving bST produced more milk (28.4 kg/d) than controls (24.1 kg/d), with variable yields among cows. For the economic analysis, induced cows were compared to first-lactation cows in the same herd using fair market value for costs and multiple component pricing for milk. Net present value for an induced cow (1966 dollars) was significantly greater than that for a first-lactation cow (1446 dollars). Our data suggest that bST use in induced cows is profitable. If a reliable method were developed and approved by the FDA, inducing nonpregnant cows into lactation could be used by dairy producers to increase profitability.     

Effect of bovine somatotropin administration during induction of lactation in 15-month-old heifers on production and health

Lactation can be induced successfully in 15-mo-old dairy heifers. Treatment of heifers induced into lactation with bovine somatotropin (bST) during an established lactation improved milk production; however, milk yields were still variable. The objective of the present study was to evaluate whether starting bST treatment during induction of lactation, rather than after lactation was established, would improve milk production beyond that of heifers induced into lactation but not treated with bST. Healthy Holstein heifers (n = 32, 15 mo of age, 420 ± 28 kg of body weight) were induced into lactation with subcutaneous injections of estradiol (0.075 mg/kg of body weight per d) and progesterone (0.25 mg/kg of body weight per d) for 7 d. Bovine somatotropin (500 mg) was administered to heifers (n = 16) beginning on experimental d 1 along with the estrogen/progesterone treatment. Heifers continued to receive bST every 2 wk for 10 wk. Control animals (n = 16) received no bST during this time. Milking began on experimental d 18, and milk production was compared through 53 d in milk (experimental d 70). Mean daily milk yield was 36% higher for bST-treated heifers than for control animals. A 15.5% difference in milk production between the groups was sustained through 305 d of lactation, even after control animals began bST treatment at 54 d in milk. Milk fat percentage was similar in bST and control heifers. Milk protein percentage was lower in bST-treated heifers (3.58%) compared with controls (3.99%) during the treatment comparison period and for the remainder of lactation (bST 3.25%, control 3.39%). Heifers treated with bST produced more total milk fat and protein compared with controls during the treatment comparison period. Throughout the induced lactation, heifers gained 0.87 kg/d and averaged 2.4 services/pregnancy; 30 became pregnant. Four heifers were culled during the induced lactation, and 28 heifers calved at 27.6 ± 2.0 mo of age for a second lactation. Addition of bST to the lactation induction protocol was advantageous because it stimulated greater milk production.     

Effects of feeding frequency and exogenous somatotropin on lipolysis, hormone profiles, and milk production in dairy cows

Effects of feeding frequency and exogenous bovine somatotropin on lactational performance and hormone profiles were examined with 12 multiparous Holstein cows. At 45 d postpartum, cows were assigned to one of two feeding systems. Concentrates were offered in two equal portions at 0800 and 1600 h or in 12 equal portions at 2-h intervals. Chopped alfalfa hay (2.6 kg/d) and barley silage (ad libitum) were fed at 0900 and 1500 h. At 136 d postpartum, cows within each feeding frequency were assigned in a single crossover design to injection of 30 mg of bST/d or solubilization vehicle. Feeding frequency did not influence any of the parameters measured nor did bST interact with feeding frequency. Somatotropin injection increased daily milk yield of cows by 4.4 kg and concentrations of fat and lactose in milk. Protein concentration and fatty acid composition of milk were not influenced by bST injection. Average plasma somatotropin concentrations were elevated threefold, peak concentrations were increased sevenfold, and concentrations at 48 h postinjection were 1.5 times control values. Plasma insulin concentrations were decreased by bST treatment. Results indicate that responses to short-term bST injection are not influenced by feeding frequency.     

Photoperiodic effects on dairy cattle: a review

Since the initial report in 1978 of galactopoietic effects of a photoperiod of 16 h of light:8 h of darkness, numerous studies have confirmed long-day stimulation of milk yield. The endocrine factor(s) responsible for increased milk yield, however, has eluded identification. Recent studies suggest that insulin-like growth factor-I (IGF-I) may mediate the galactopoietic response to long day photoperiod. Indeed, long days increase IGF-I in heifers and lactating cows; in the latter case, the response preceded an increase in milk yield. In heifers and cows, the increase in IGF-I is independent of changes in circulating growth hormone. Melatonin feeding to mimic a short-day photoperiod suppressed the increase of IGF-I in heifers induced by long days. However, melatonin feeding had no effect on milk yield in cows. Despite lack of resolution of the endocrine mechanism, dairy producers are interested in how photoperiod management can be integrated with current practices throughout the lactation cycle. There is strong evidence that milk yield responses to long days persist through an entire lactation. Also, long days can be combined with bovine somatotropin (bST) to produce additive increases in milk yield. During the dry period, long days increase the periparturient surge of prolactin. However, relative to long days, short-day treatment during the dry period produces the largest magnitude of response in milk yield during the subsequent lactation. The response to short days during the dry period may be due to a priming effect on the photoperiodic response system. In summary, IGF-I has emerged as a possible mediator of the increase of milk yield in response to long-day photoperiod. Photoperiod can be combined effectively with other management techniques such as bST. Consideration of photoperiod management during the dry period is essential to maximize responses during the subsequent lactation.